Finanztrends
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
?
W******* i* V********
?
L*********** I********** f** d** n******* J****
?
M************
Kontra
?
A****************
?
M****
?
U****************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | 0,00 % | 14,42 % | 11,74 % | -14,23 % | 17,82 % | 132,20 % | - |
| Larimar Therapeutics Inc. | -2,80 % | -5,56 % | -20,00 % | -18,56 % | -18,07 % | -36,45 % | -83,13 % |
| Vaxart Inc. | - | 144,44 % | 135,71 % | -4,14 % | 135,71 % | -37,46 % | -88,32 % |
News
Stock Market Today, Jan. 13: Nvidia Rises on H200 Export Developments
AI giant, Nvidia (NASDAQ:NVDA), closed Tuesday’s session at $185.81, up 0.47%. Trading volume reached 158.40 million shares, coming in 16.51% below its three-month average of 184.56 million shares.
Stock Market Today, Jan. 13: AMD Rallies as Banking Stocks Struggle
The S&P 500 (SNPINDEX:^GSPC) slipped 0.19% to 6,963.74 today even as December CPI data came in slightly lower than expected. The Nasdaq Composite (NASDAQINDEX:^IXIC) eased 0.10% to 23,709.87, and
Buy These 3 AI ETFs Now: They Could Be Worth $15 Million in 30 Years
There is no hotter segment of the market right now than artificial intelligence (AI). AI stocks have powered the market higher over the past few years, and the technology still looks like it is in